Montelukast Impurity NEW

Montelukast Impurity ;1100617-38-6

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

• Product Number: M012022
  English Name: Montelukast Impurity 22
  English Alias: (S,E)-3-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-4,5-dihydrobenzo[c]oxepin-1(3H)-one
  CAS Number: 1100617-38-6
  Molecular Formula: C₂₇H₂₀ClNO₂
  Molecular Weight: 425.91
• 
  
• Product Advantages: Montelukast Impurity 22 has high purity and good chemical stability. With a clear structure and uniform properties, it remains stable under different experimental conditions and can be used as a reliable reference substance for Montelukast impurity analysis. Its precise characteristics can ensure the accuracy and repeatability of detection results, providing a solid basis for pharmaceutical quality research and quality control.
  Application Fields: It is mainly applied in the quality control and research and development process of Montelukast-related drugs. As an impurity reference standard, it is used to establish and validate the detection methods of Montelukast impurities, ensuring the sensitivity and specificity of detection methods. During the drug production process, it is used to monitor the content of this impurity, assist in optimizing the production process, and prevent excessive impurities from affecting drug quality. In the study of drug stability, it analyzes its changes during storage, providing important references for determining the shelf life and storage conditions of drugs.
  Background Description: Montelukast is a drug commonly used in the treatment of asthma and allergic rhinitis. In its research, development, production and quality control, impurity research is of great significance. The presence of impurities may affect the safety, effectiveness and stability of drugs. As a related impurity of Montelukast, in-depth research on Montelukast Impurity 22 helps to comprehensively evaluate the quality of Montelukast drugs and ensure the safety and effectiveness of clinical medication.
  Research Status: Currently, research on Montelukast Impurity 22 continues to advance. In terms of detection technology, advanced methods such as Ultra-Performance Liquid Chromatography-Mass Spectrometry (UPLC-MS) and high-resolution mass spectrometry are constantly being explored to achieve accurate detection of trace impurities. In the study of impurity generation mechanisms, the formation causes and influencing factors are deeply analyzed by simulating drug synthesis reactions and storage environments, providing theoretical support for controlling impurities from the source. At the same time, research on the interaction between this impurity and Montelukast and its impact on drug efficacy and safety is also gradually carried out, aiming to improve the comprehensive understanding of the quality of Montelukast drugs.

NOTE！

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery!